Harrow (HROW) EBITDA Margin (QoQ) (2013 - 2026)
Harrow (HROW) EBITDA Margin (QoQ) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | Harrow | 1.23 Bn | 1.14 Bn | 27.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6,745.00 |
| Dec 31, 2025 | -309.00 |
| Sep 30, 2025 | 269.00 |
| Jun 30, 2025 | 4,138.00 |
| Mar 31, 2025 | -4,278.00 |
| Dec 31, 2024 | 1,662.00 |
| Sep 30, 2024 | -44.00 |
| Jun 30, 2024 | 2,316.00 |
| Mar 31, 2024 | -662.00 |
| Dec 31, 2023 | -1,850.00 |
| Sep 30, 2023 | -194.00 |
| Jun 30, 2023 | 239.00 |
| Mar 31, 2023 | 1,338.00 |
| Dec 31, 2022 | -833.00 |
| Sep 30, 2022 | -766.00 |
| Jun 30, 2022 | -225.00 |
| Mar 31, 2022 | 1,819.00 |
| Dec 31, 2021 | 1,117.00 |
| Sep 30, 2021 | -4,286.00 |
| Jun 30, 2021 | 410.00 |